Innoviom’s Wowie™ Continues to Bring New Innovation to the CBD Beverage Market


Ryan Allway

May 18th, 2020

Exclusive, News, Top Story


In 2004, Manoj Bhargava came up with the idea of a sugar-free energy drink with a twist—it came in a  2.49 fluid ounces “shot”. He launched 5-hour Energy in 2004, Walmart picked it up in 2006, and it surpassed $1 billion in retail sales by 2011. This new innovation was incremental to the already established energy drink market.

Innoviom hopes to replicate the success of 5-hour Energy with its new Wowie™ Shots. In addition to the convenient size, Wowie™ Shots have a twist of their own—they contain 20mg of cannabidiol, better known as CBD, per serving and focus on relaxation rather than energy!

Innoviom shots

CBD Demand on the Rise

CBD has become one of the most popular health and wellness products in the world over the past 12 months. While scientists are only beginning to understand the potential medical benefits, there has been no shortage of anecdotal benefits among consumers.

There are many different types of CBD products on the market, ranging from bath bombs to dog treats. Consumers are using these products to help with everything from chronic anxiety to sleep disorders—although clinical studies remain in the early stages.

These products were historically limited to online sales, but the 2018 Farm Bill removed hemp (a common source of CBD) from the Schedule I Controlled Substances list, which led to a boom of products appearing on the shelves of mass-market retailers.

Combining Two Megatrends

Innoviom is combining two megatrends with the launch of Wowie™ Shots—CBD and the convenient “shot” format. While consumers are embracing CBD, 5-hour Energy has demonstrated clear demand for “shots” with its nearly $1 billion in estimated annual sales.

Both “shot” drinks and CBD attract young men between the ages of 25 and 45. While traditional “energy” shots help those experiencing fatigue in the morning or during work, CBD products help those experiencing anxiety during their hectic daily lives in the occasions where fast stress-relief is required. They have historically targeted different outcomes.

Wowie™ Shots contain a unique blend of hemp-derived CBD from U.S. sources and adaptogens that help the body cope with environmental stress factors, helping address everything from adrenal fatigue to sleep disorders. By packaging the CBD in a convenient shot format, consumers can access the same easy format that energy shots pioneered.

Accredited investor? Click here to learn more about the investment opportunity

Adding to a Diverse Line Up

Innoviom has developed an innovative line-up of functional beverages based on herbal ingredients. Tranquini®, its flagship brand, leverages adaptogens, or natural bioregulators that increase the ability to adapt to environmental stress factors.Wowie™ by Tranquini is a line of low-calorie relaxation beverages with 20mg of hemp-derived CBD per can and its proprietary mix of adaptogens. These products are already for sale across the company’s distribution network, including Amazon.com.

Led by major beverage and CPG executives, from companies like Coca-Cola, Diageo, Red Bull, Gillette, and PepsiCo, the company is uniquely qualified to drive growth across different emerging categories and in international markets.

Looking Ahead

Innoviom is well-positioned to capitalize on the CBD and “shot” trends with its new Wowie™ Shots. With distribution already set up, the company could quickly become a category leader in the CBD beverage space. If you’re an accredited investor, click here to learn more about how to invest in the company as it gears up commercialization in the functional beverage market.

Follow us on social media:

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading